APA (7th ed.) Citation

M, S., CD, E., A, O., GM, M., H, C., R, O., . . . BE, Y. (2024). Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy. JAMA neurology, 81(5), 499. https://doi.org/10.1001/jamaneurol.2024.0551

Chicago Style (17th ed.) Citation

M, Spotnitz, et al. "Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy." JAMA Neurology 81, no. 5 (2024): 499. https://doi.org/10.1001/jamaneurol.2024.0551.

MLA (9th ed.) Citation

M, Spotnitz, et al. "Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy." JAMA Neurology, vol. 81, no. 5, 2024, p. 499, https://doi.org/10.1001/jamaneurol.2024.0551.